Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medical has completed its acquisition of Nevro, broadening its market presence in musculoskeletal solutions.

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its ...

The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems - ...

StockNews.com assumed coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the medical equipment provider’s stock. Other equities ...

Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Multiple sclerosis causes lesions to the spinal cord and other parts of the central nervous system. An MRI can detect spinal cord lesions and help diagnose and monitor the condition. Multiple ...

Most recently, Mr. Galligan served as Chief Financial Officer at Nevro Corp., a medical device company in the implantable spinal cord stimulation market. During his 10-year tenure at Nevro, he built ...